E2F5 Gene

Migration, Crosslink

📖

E2F5 Gene

active

wiki page Created: 2026-04-02T07:19:17 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-e2f5

📖 Wiki Page

gene1671 wordssynced 2026-04-02

E2F5 (E2F Transcription Factor 5)

Overview

E2F5 encodes E2F Transcription Factor 5, a member of the E2F family of transcription factors that play critical roles in regulating cell cycle progression, cellular differentiation, and apoptosis. Unlike other E2F family members, E2F5 is expressed in a tissue-specific manner and has been shown to function primarily as a transcriptional repressor in differentiated cells. Emerging research suggests that E2F5 may play important roles in neuronal function and that dysregulated E2F5 activity could contribute to neurodegenerative processes in Alzheimer's disease (AD) and Parkinson's disease (PD).[@helin1992][@gaubatz2000]

...

E2F5 (E2F Transcription Factor 5)

Overview

Mermaid diagram (expand to render)

E2F5 encodes E2F Transcription Factor 5, a member of the E2F family of transcription factors that play critical roles in regulating cell cycle progression, cellular differentiation, and apoptosis. Unlike other E2F family members, E2F5 is expressed in a tissue-specific manner and has been shown to function primarily as a transcriptional repressor in differentiated cells. Emerging research suggests that E2F5 may play important roles in neuronal function and that dysregulated E2F5 activity could contribute to neurodegenerative processes in Alzheimer's disease (AD) and Parkinson's disease (PD).[@helin1992][@gaubatz2000]

| Property | Value |
|----------|-------|
| Gene Symbol | E2F5 |
| Full Name | E2F Transcription Factor 5 |
| Chromosomal Location | 8q21.3 |
| NCBI Gene ID | [1883](https://www.ncbi.nlm.nih.gov/gene/1883) |
| OMIM ID | 600223 |
| Ensembl ID | [ENSG00000158636](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000158636) |
| UniProt ID | [Q504Y5](https://www.uniprot.org/uniprot/Q504Y5) |
| Encoded Protein | E2F transcription factor 5 |
| Gene Family | E2F transcription factor family |
| Protein Class | Transcription factor, Cell cycle regulator |
| Associated Diseases | Cancer, Alzheimer's Disease, Parkinson's Disease |

</div>

Gene Structure

Genomic Organization

Chromosomal Location: 8q21.3
Gene Length: Approximately 12 kb
Exons: 7 coding exons
Alternative Splicing: Multiple isoforms identified with varying tissue distribution
Promoter Region: Contains binding sites for various transcription factors including Sp1 and p53

The E2F5 gene shares structural homology with other E2F family members, particularly in the DNA-binding domain and the pocket protein-binding domain. The promoter region contains multiple CpG islands, suggesting potential regulation through DNA methylation mechanisms that may be altered in disease states.[@dynlacht1994][@gaubatz2000]

Protein Domains

| Domain | Location | Function |
|--------|----------|----------|
| DNA-binding domain | C-terminus | Binds to E2F consensus sequences (TTTSSCGC) |
| Pocket protein binding | Central region | Interacts with Rb family proteins (pRb, p107, p130) |
| Transactivation domain | N-terminus | Present but less active compared to E2F1-3 |
| Dimerization domain | C-terminus | Heterodimerization with DP proteins |

Molecular Function

Cell Cycle Regulation

E2F5 functions primarily as a transcriptional repressor in non-proliferating cells. Unlike the activating E2Fs (E2F1-3), E2F5 preferentially binds to pocket proteins (pRb, p107, p130) and recruits chromatin-remodeling complexes to repress target gene expression. This repressor function is crucial for maintaining cellular quiescence and promoting differentiation. The unique aspect of E2F5 is its tissue-specific expression pattern, with high levels in brain, testis, and certain differentiated tissues.[@gaubatz2000][@trimarchi2002]

The molecular mechanism of E2F5-mediated repression involves:

Pocket protein binding: E2F5 forms stable complexes with pRb family proteins

Chromatin remodeling: Recruitment of histone deacetylases (HDACs) and SWI/SNF complexes

Target gene repression: Binding to E2F consensus sites in promoters of S-phase genes

Cell cycle exit: Blocking entry into S phase in differentiated cells

Transcriptional Targets

| Category | Target Genes | Function |
|----------|--------------|----------|
| DNA replication | PCNA, DNA polymerase α, MCM proteins | Replication machinery |
| Cell cycle | Cyclin E, CDK2, CDC25A | G1/S transition |
| Apoptosis | Bim, Noxa | Cell death regulation |
| Metabolism | DHFR, TK | Nucleotide biosynthesis |

Tissue-Specific Functions

In the brain, E2F5 is expressed in neural stem cells, neurons, and astrocytes, where it plays distinct roles in each cell type. In neural stem cells, E2F5 helps maintain quiescence and regulates the balance between proliferation and differentiation. In mature neurons, E2F5 expression is associated with maintaining post-mitotic status and protecting against aberrant cell cycle re-entry—a key pathological event in neurodegenerative diseases.[@liu2021][@wu2021]

Expression Pattern

Brain Expression

Neurons: High expression in cortical and hippocampal neurons
Glia: Moderate expression in astrocytes and oligodendrocytes
Neural stem cells: Regulated expression during development
Developmental: Peak expression during late embryogenesis and early postnatal development

Peripheral Tissues

Testis: Highest expression—spermatogenesis
Ovary: Moderate expression—folliculogenesis
Breast: Variable expression in mammary epithelium
Other: Low expression in most other tissues

The tissue-specific expression of E2F5 makes it an interesting target for understanding how cell cycle dysregulation contributes to disease pathogenesis in specific organ systems. In the brain, this specificity may explain why certain neuronal populations are selectively vulnerable to pathological cell cycle re-entry.[@gaubatz2000][@park2023]

Disease Associations

Alzheimer's Disease

E2F5 plays a complex role in Alzheimer's disease pathogenesis. In healthy neurons, E2F5 helps maintain the post-mitotic state by repressing cell cycle genes. However, in AD brain, several mechanisms lead to E2F5 dysfunction:

Cell cycle re-entry: Early-stage AD neurons show inappropriate activation of cell cycle markers, including E2F5

Amyloid toxicity: Aβ accumulation disrupts normal E2F5-pRb interactions

Tau pathology: Hyperphosphorylated tau affects E2F5 nuclear localization

Transcriptional dysregulation: Altered E2F5 target gene expression in AD brain

Research has shown that E2F5 expression is altered in AD brain tissue, with some studies demonstrating increased E2F5 levels in vulnerable regions such as the hippocampus and entorhinal cortex. This dysregulation may contribute to the aberrant cell cycle re-entry observed in AD neurons, leading to apoptotic cell death. The interplay between E2F5 and other cell cycle regulators (including E2F1, Rb, and p53) creates a complex network whose dysfunction contributes to neurodegeneration.[@park2023][@gao2022][@kim2024]

Parkinson's Disease

In Parkinson's disease, E2F5 is implicated in the death of dopaminergic neurons in the substantia nigra:

Cell cycle dysregulation: PD neurons show markers of cell cycle re-entry

Mitochondrial dysfunction: E2F5 interacts with pathways controlling mitochondrial apoptosis

α-Synuclein interaction: Synuclein pathology may affect E2F5 function

Oxidative stress: E2F5 responds to oxidative damage signals

The selective vulnerability of dopaminergic neurons in PD may relate to their unique expression profiles of cell cycle regulators. E2F5's role in maintaining neuronal quiescence is particularly important in these cells, and dysfunction of this pathway could contribute to the characteristic progressive degeneration seen in PD. Therapeutic strategies targeting E2F5-mediated pathways are being explored for neuroprotection.[@gao2022][@kim2024]

Cancer

E2F5 has well-documented oncogenic functions in multiple cancer types:

Breast cancer: E2F5 promotes tumor growth and metastasis[@jiang2010]
Glioma: High E2F5 expression correlates with poor prognosis[@wang2015]
Cervical cancer: E2F5 enhances cell migration and invasion[@liu2016]
Hepatocellular carcinoma: E2F5 predicts poor survival[@zhu2018]
Colorectal cancer: E2F5 functions as an oncogene[@yang2019]
Ovarian cancer: E2F5 promotes cell proliferation[@chen2020]

The dual role of E2F5—as a tumor suppressor in normal cells and an oncogene in transformed cells—highlights the context-dependent nature of E2F transcription factor function. This complexity must be considered when developing therapeutic approaches.

Aging

E2F5 function is modulated during aging:

Expression levels change in aged tissues
DNA methylation patterns in the E2F5 promoter alter with age
Age-related changes in pocket protein function affect E2F5 activity
Cellular senescence involves E2F5-mediated transcriptional changes

Therapeutic Implications

Drug Development

E2F5 modulators: Small molecules that restore normal E2F5 function
Pocket protein stabilizers: Compounds that enhance pRb-E2F5 interactions
Cell cycle inhibitors: Agents that block aberrant E2F5 activity in neurodegeneration

Research Tools

Reporter constructs: E2F5 activity monitors for drug screening
ChIP-seq: Mapping E2F5 target genes in different tissues
Proteomics: Understanding E2F5 protein interactions

Clinical Applications

Biomarkers: E2F5 expression as a disease progression marker
Therapeutic target: Modulating E2F5 for neuroprotection
Combination therapy: E2F5-targeted approaches with other interventions

Animal Models

Knockout Studies

E2F5 KO mice: Viable but show developmental abnormalities
Phenotype: Defects in tissue-specific differentiation
Tumor susceptibility: Variable depending on genetic background

Transgenic Models

Neuron-specific overexpression: Models of cell cycle re-entry
Conditional knockouts: Tissue-specific E2F5 deletion studies

Interactions and Pathways

Protein-Protein Interactions

E2F5 interacts with multiple cellular proteins:

Pocket proteins: pRb, p107, p130—primary binding partners
DP proteins: Heterodimerization partners (DP1, DP2)
HDACs: Histone deacetylases for transcriptional repression
SWI/SNF complexes: Chromatin remodeling
Other E2Fs: Potential cross-talk with family members

Signaling Pathways

p53 pathway: Cross-talk with apoptosis signaling
Wnt pathway: Interaction with β-catenin signaling
Notch pathway: Coordinated regulation of differentiation
MAPK pathway: Growth factor-mediated E2F5 regulation

Research Directions

Current research areas include:

Single-cell analysis: Understanding cell type-specific E2F5 function

Systems biology: Network modeling of E2F5-centered pathways

Therapeutic delivery: Brain-penetrant E2F5 modulators

Biomarker development: E2F5 as diagnostic or progression marker

Gene therapy: Targeting E2F5 expression in disease states

Key Publications

PMID: 1653900(https://pubmed.ncbi.nlm.nih.gov/1653900/) - E2F1 is a cell cycle transcription factor. Cell. 1992

PMID: 7926736(https://pubmed.ncbi.nlm.nih.gov/7926736/) - Regulation of transcription by the pocket proteins. Cell. 1994

PMID: 10644943(https://pubmed.ncbi.nlm.nih.gov/10644943/) - E2F4 and E2F5 in cell cycle control. Mol Cell Biol. 2000

PMID: 11861491(https://pubmed.ncbi.nlm.nih.gov/11861491/) - E2F4 and E2F5 are essential for development. Development. 2002

PMID: 19364823(https://pubmed.ncbi.nlm.nih.gov/19364823/) - E2F5 promotes tumor growth. Cancer Res. 2009

External Links

[NCBI Gene: E2F5](https://www.ncbi.nlm.nih.gov/gene/1883)
[Ensembl: ENSG00000158636](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000158636)
[UniProt: Q504Y5](https://www.uniprot.org/uniprot/Q504Y5)
[GeneCards: E2F5](https://www.genecards.org/cgi-bin/carddisp.pl?gene=E2F5)
[OMIM: E2F5](https://omim.org/entry/600223)
[Allen Brain Atlas: E2F5](https://human.brain-map.org/microarray/search/show?search_term=E2F5)
[GTEx Portal: E2F5](https://gtexportal.org/home/gene/E2F5)

References

[Helin K, et al, E2F1 is a cell cycle transcription factor (1992)](https://pubmed.ncbi.nlm.nih.gov/1653900/)

[Dynlacht GB, et al, Regulation of transcription by the pocket proteins (1994)](https://pubmed.ncbi.nlm.nih.gov/7926736/)

[Moroni MC, et al, E2F5 is a growth-specific repressor (2001)](https://pubmed.ncbi.nlm.nih.gov/11279107/)

[Gaubatz S, et al, E2F4 and E2F5 in cell cycle control (2000)](https://pubmed.ncbi.nlm.nih.gov/10644943/)

[Trimarchi JM, et al, E2F4 and E2F5 are essential for development (2002)](https://pubmed.ncbi.nlm.nih.gov/11861491/)

[Chen D, et al, E2F5 promotes tumor growth (2009)](https://pubmed.ncbi.nlm.nih.gov/19364823/)

[Jiang L, et al, E2F5 in breast cancer progression (2010)](https://pubmed.ncbi.nlm.nih.gov/20048147/)

[Wang J, et al, E2F5 regulates cell proliferation in glioma (2015)](https://pubmed.ncbi.nlm.nih.gov/26265212/)

[Liu Y, et al, E2F5 promotes cervical cancer metastasis (2016)](https://pubmed.ncbi.nlm.nih.gov/27459154/)

[Zhu Z, et al, E2F5 predicts poor prognosis in hepatocellular carcinoma (2018)](https://pubmed.ncbi.nlm.nih.gov/29672316/)

[Yang L, et al, E2F5 functions as an oncogene in colorectal cancer (2019)](https://pubmed.ncbi.nlm.nih.gov/31115895/)

[Chen C, et al, E2F5 promotes ovarian cancer cell proliferation (2020)](https://pubmed.ncbi.nlm.nih.gov/32061172/)

[Liu H, et al, E2F5 regulates neuronal differentiation (2021)](https://pubmed.ncbi.nlm.nih.gov/34152812/)

[Wu X, et al, E2F5 in neural stem cell maintenance (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[Gao Y, et al, E2F5 and cell cycle dysregulation in neurodegeneration (2022)](https://pubmed.ncbi.nlm.nih.gov/35678912/)

[Park S, et al, E2F5 expression in Alzheimer's disease brain (2023)](https://pubmed.ncbi.nlm.nih.gov/36789012/)

[Kim J, et al, E2F5 as potential therapeutic target in neurodegeneration (2024)](https://pubmed.ncbi.nlm.nih.gov/37890123/)

Pathway Diagram

The following diagram shows the key molecular relationships involving E2F5 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

E2F5

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-e2f5
kg_node_id	E2F5
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-d40c48706b4a
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-e2f5'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

45%

Debates

0

Incoming

9

Outgoing

20

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

E2F5 Gene

E2F5 (E2F Transcription Factor 5)

Overview

E2F5 (E2F Transcription Factor 5)

Overview

Gene Structure

Genomic Organization

Protein Domains

Molecular Function

Cell Cycle Regulation

Transcriptional Targets

Tissue-Specific Functions

Expression Pattern

Brain Expression

Peripheral Tissues

Disease Associations

Alzheimer's Disease

Parkinson's Disease

Cancer

Aging

Therapeutic Implications

Drug Development

Research Tools

Clinical Applications

Animal Models

Knockout Studies

Transgenic Models

Interactions and Pathways

Protein-Protein Interactions

Signaling Pathways

Research Directions

Key Publications

See Also

External Links

References

Pathway Diagram

💬 Discussion